Literature DB >> 20025941

Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals.

Jason P Berninger1, Bryan W Brooks.   

Abstract

Comparative pharmacology and toxicology approaches with fish models provide important linkages between the biomedical and environmental sciences. Because chronic fish responses to select pharmaceuticals are observed at very low (e.g., ng/L) concentrations, approaches are needed to identify therapeutics for robust environmental hazard and risk assessments. Whereas we observed no obvious relationship between acute toxicity data for rodent (LD(50)) and fish (LC(50)) models, using a probabilistic hazard evaluation approach, rodent and fish acute toxicity distributions predicted limited potential for acute toxicity at low concentrations, which is consistent with the peer-reviewed literature. Similar probabilistic distributions were developed to examine mammalian C(max) and an Acute to Therapeutic Ratio (ATR), a surrogate for mammalian therapeutic index that is similar to an Acute to Chronic Ratios (ACRs) commonly calculated for fish models. Probabilistic distributions of ATRs for fifteen drug classes were also examined, which showed specific groups with higher (e.g., reproductive hormones, corticosteroids, antihistamines) and lower (e.g., antibiotics, NSAIDs) ATR values than the distribution for all available pharmaceutical ATRs. A statistically significant relationship (r(2)=0.846, p<0.001) was determined between mammalian ATR and fish ACR values, which may support a screening approach to examine chronic pharmaceutical effects in fish based on the magnitude of mammalian ATR values. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025941     DOI: 10.1016/j.toxlet.2009.12.006

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  15 in total

1.  Prioritizing environmental risk of prescription pharmaceuticals.

Authors:  Zhao Dong; David B Senn; Rebecca E Moran; James P Shine
Journal:  Regul Toxicol Pharmacol       Date:  2012-07-17       Impact factor: 3.271

2.  Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments.

Authors:  Kristin A Connors; Theodore W Valenti; Kelly Lawless; James Sackerman; Emmanuel S Onaivi; Bryan W Brooks; Georgianna G Gould
Journal:  Aquat Toxicol       Date:  2013-12-12       Impact factor: 4.964

3.  Age matters: Developmental stage of Danio rerio larvae influences photomotor response thresholds to diazinion or diphenhydramine.

Authors:  Lauren A Kristofco; Luis Colon Cruz; Samuel P Haddad; Martine L Behra; C Kevin Chambliss; Bryan W Brooks
Journal:  Aquat Toxicol       Date:  2015-09-25       Impact factor: 4.964

Review 4.  Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms.

Authors:  Carlie A LaLone; Jason P Berninger; Daniel L Villeneuve; Gerald T Ankley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-11-19       Impact factor: 6.237

5.  Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows.

Authors:  Theodore W Valenti; Georgianna G Gould; Jason P Berninger; Kristin A Connors; N Bradley Keele; Krista N Prosser; Bryan W Brooks
Journal:  Environ Sci Technol       Date:  2012-02-07       Impact factor: 9.028

6.  Comparative pharmacology and toxicology of pharmaceuticals in the environment: diphenhydramine protection of diazinon toxicity in Danio rerio but not Daphnia magna.

Authors:  Lauren A Kristofco; Bowen Du; C Kevin Chambliss; Jason P Berninger; Bryan W Brooks
Journal:  AAPS J       Date:  2014-10-18       Impact factor: 4.009

7.  In Silico Models for Ecotoxicity of Pharmaceuticals.

Authors:  Kunal Roy; Supratik Kar
Journal:  Methods Mol Biol       Date:  2016

Review 8.  Pharmaceuticals and personal care products in the environment: what are the big questions?

Authors:  Alistair B A Boxall; Murray A Rudd; Bryan W Brooks; Daniel J Caldwell; Kyungho Choi; Silke Hickmann; Elizabeth Innes; Kim Ostapyk; Jane P Staveley; Tim Verslycke; Gerald T Ankley; Karen F Beazley; Scott E Belanger; Jason P Berninger; Pedro Carriquiriborde; Anja Coors; Paul C Deleo; Scott D Dyer; Jon F Ericson; François Gagné; John P Giesy; Todd Gouin; Lars Hallstrom; Maja V Karlsson; D G Joakim Larsson; James M Lazorchak; Frank Mastrocco; Alison McLaughlin; Mark E McMaster; Roger D Meyerhoff; Roberta Moore; Joanne L Parrott; Jason R Snape; Richard Murray-Smith; Mark R Servos; Paul K Sibley; Jürg Oliver Straub; Nora D Szabo; Edward Topp; Gerald R Tetreault; Vance L Trudeau; Glen Van Der Kraak
Journal:  Environ Health Perspect       Date:  2012-05-30       Impact factor: 9.031

9.  Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.

Authors:  Luigi Margiotta-Casaluci; Stewart F Owen; Rob I Cumming; Anna de Polo; Matthew J Winter; Grace H Panter; Mariann Rand-Weaver; John P Sumpter
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

Review 10.  Current perspectives on the use of alternative species in human health and ecological hazard assessments.

Authors:  Edward J Perkins; Gerald T Ankley; Kevin M Crofton; Natàlia Garcia-Reyero; Carlie A LaLone; Mark S Johnson; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Health Perspect       Date:  2013-06-14       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.